Paul has been a consultant to Kaufhold and Dix Patent Law since 2015.
Paul managed the day-to-day operation of a highly-virtual company that performed a Phase 2 clinical study testing Biologically Modified Vein Grafts in Coronary Artery Bypass (CABG). His responsibilities also included intellectual property management.
At Cellgate, Paul assumed a lead role in development efforts for the company’s primary drug candidate, PsorBan®, and worked with outside counsel to secure patent protection.
At Roche, Paul developed scalable processes for the manufacture of molecules of pharmaceutical interest and transferred these processes to other Roche sites and outside manufacturers.
At Pfizer, Paul conceived and implemented a new and highly advantageous route to Sorbestrin™ that was successfully scaled to pilot plant level.
As a Postdoctoral Research Associate, Paul played a vital role in designing and executing a total synthesis of the chemotherapeutic agent Taxol®.
As a Summer Intern, Paul developed methods for the formation of superconducting thin films utilizing spray pyrolysis.
Paul enjoys traveling with his wife for both business and pleasure, especially the 6-12 weeks per winter that they spend in Mexico. During the fall, Paul enjoys hunting pheasants, partridge, and quail with family and friends. Paul is also an inventor, having 16 patents.
Paul enjoys traveling with his wife for both business and pleasure, especially the 6-12 weeks per winter that they spend in Mexico. During the fall, Paul enjoys hunting pheasants, partridge, and quail with family and friends. Paul is also an inventor, having 16 patents.